The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated ...
The NZD/USD pair is testing a critical support level at 0.5650. A decisive break below this level could push the pair toward ...
EMA establishes regular procedure for scientific advice on certain high-risk medical devices: Amsterdam, The Netherlands Wednesday, February 12, 2025, 13:00 Hrs [IST] EMA, in clos ...
USD/JPY is extending gains above 153.50 in Wednesday's Asian trading. The Japanese Yen continues losing ground amid latest ...
USD/JPY traders eye Japan’s machine tool orders and US CPI data for market direction. Will softer inflation revive Fed rate ...
GOMEKLIâ„¢ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
Biogen Inc. (NASDAQ:BIIB) shares tumbled to a 52-week low of $139.7, reflecting a stark downturn in the biotechnology firm's market performance. With a market capitalization of $20.38 billion and a ...
The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...
The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
1 Christoffersen M et al. Transthyretin Tetramer Destabilization and Increased Mortality in the General Population. JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback